Literature DB >> 2899057

Studies on the adjuvant action of beryllium. IV. The preparation of beryllium containing macromolecules that induce immunoblast responses in vivo.

J G Hall1.   

Abstract

Solutions of BeSO4 were added to soluble macromolecules and the mixtures brought to neutrality. Under appropriate conditions much of the beryllium did not precipitate out as insoluble hydroxides but became attached to naturally occurring sulphated proteoglycans and polysaccharides (e.g. heparin, chondroitin sulphate, fucoidan, etc.) and to synthetic, sulphonated aromatic dyestuffs (e.g. trypan, Evans and Coomassie blues, Suramin, etc.). At physiological conditions of pH and ionic strength, these addition compounds were relatively stable and did not dissociate during dialysis. When such materials were injected s.c. into sheep (in doses containing about 50 micrograms Be), rapid lymphoproliferative responses took place in the regional nodes so that immunoblasts appeared in the efferent lymph in numbers that exceeded those provoked by powerful conventional antigenic stimuli. Significant amounts of the injected materials passed through the nodes and, in intact animals, became systematized. A method was devised for attaching beryllium to particulate carriers, such as lymphocytes or red cells that had been fixed with glutaraldehyde. The injection of suspensions of such materials also provoked vigorous immunoblastic responses, but the particulate materials did not pass beyond the regional node. In the doses usually used, none of these materials was grossly toxic and they may be suitable for consideration for development into a new type of immunostimulator cum adjuvant.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899057      PMCID: PMC1384967     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  The response of the popliteal lymph node of the sheep to swine influenza virus.

Authors:  J B Smith; B Morris
Journal:  Aust J Exp Biol Med Sci       Date:  1970-02

2.  The immediate effect of antigens on the cell output of a lymph node.

Authors:  J G Hall; B Morris
Journal:  Br J Exp Pathol       Date:  1965-08

3.  Studies on the lymphocytes of sheep. III. Destination of lymph-borne immunoblasts in relation to their tissue of origin.

Authors:  J G Hall; J Hopkins; E Orlans
Journal:  Eur J Immunol       Date:  1977-01       Impact factor: 5.532

4.  Studies of efferent lymph cells from nodes stimulated with oxazolone.

Authors:  J G Hall; J Hopkins; J Reynolds
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397

5.  Effects of trypan blue treatment on the immune responses of mice.

Authors:  M L Kripke; K C Norbury; E Gruys; J B Hibbs
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

6.  Binding of beryllium to nuclear acidic proteins.

Authors:  V H Parker; C Stevens
Journal:  Chem Biol Interact       Date:  1979-07       Impact factor: 5.192

7.  Letter: Immunoblactic lymphadenopathy associated with phenytoin (diphenylhydantoin).

Authors:  M J Lapes; R J Vivacqua; K Antoniades
Journal:  Lancet       Date:  1976-01-24       Impact factor: 79.321

8.  Suramin effects on macrophage phagolysosome formation and antimicrobial activity.

Authors:  E L Pesanti
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

9.  Evans blue dye adjuvant enhances delayed hypersensitivity while blocking immunity to Mycobacterium tuberculosis in mice.

Authors:  D W Anderson; A J Crowle
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

10.  The ultrastructure and function of the cells in lymph following antigenic stimulation.

Authors:  J G Hall; B Morris; G D Moreno; M C Bessis
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

View more
  3 in total

1.  The endolymphatic perfusion of lymph nodes with toxic materials.

Authors:  J G Hall; H D Sinnett
Journal:  Br J Exp Pathol       Date:  1989-06

Review 2.  Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.

Authors:  Sarah A Greaves; Shaikh M Atif; Andrew P Fontenot
Journal:  Front Immunol       Date:  2020-03-18       Impact factor: 7.561

Review 3.  Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs.

Authors:  Nikolai Petrovsky
Journal:  Drug Saf       Date:  2015-11       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.